Pain targeting mechanisms
The demand for new therapeutic strategies for pain is high because established drugs have major limitations, including lack of efficacy for conditions such as neuropathic pain and the potential for abuse for opioids. In this webcast, several companies that are working to target unmet needs in pain management will present their developments, which include analgesics with novel mechanisms of action, opioids with reduced potential for abuse and medical devices.
The webcast will also include a roundtable discussion and a Q&A section to allow you to hear direct expert opinions from the speakers and contribute your own thoughts.
BioPharma Dealmakers webcasts are dedicated to small and large companies looking for commercial partnerships. Read the quarterly BioPharma Dealmakers supplement in Nature Biotechnology and Nature Reviews Drug Discovery.
Webcast sponsors retain sole responsibility for content.
Director of Product Development and Principal Scientist
Senior Vice President and Chief Scientific Officer